Does TOFACITINIB Cause Aphonia? 248 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 248 reports of Aphonia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.2% of all adverse event reports for TOFACITINIB.
248
Reports of Aphonia with TOFACITINIB
0.2%
of all TOFACITINIB reports
0
Deaths
36
Hospitalizations
How Dangerous Is Aphonia From TOFACITINIB?
Of the 248 reports, 36 (14.5%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Aphonia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 248 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Aphonia?
AMIKACIN (465)
ADALIMUMAB (397)
OMALIZUMAB (338)
FLUTICASONE\SALMETEROL (300)
ETANERCEPT (278)
BUDESONIDE\FORMOTEROL (274)
DUPILUMAB (259)
TIOTROPIUM (227)
LENALIDOMIDE (207)
SECUKINUMAB (190)
Which TOFACITINIB Alternatives Have Lower Aphonia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN